非价格竞争策略下我国试剂类企业的商业前景和竞争力分析  

Analysis on the Commercial Prospects and Competitiveness of China’s Reagent Enterprises under the Non-price Competition Strategy

作　　者：顾津瑜 GU Jinyu(School of Business,Nanjing University)

机构地区：[1]南京大学商学院经济学系

出　　处：《中国商论》2021年第18期136-138,共3页China Journal of Commerce

摘　　要：近年来国内体外诊断试剂行业进入飞速发展阶段,但由于国内企业开始时间晚,发展时间短,同国外企业相比存在着较大的差距,目前国内市场主要被国外企业所垄断。本文从非价格竞争策略入手,探究如何提升我国体外诊断试剂类企业竞争力,主要分析了体外诊断试剂行业的市场结构及其技术创新,强调了推动产业集中化发展和大企业向价值链上游延伸发展的重要性。In recent years,the domestic in vitro diagnostic reagent industry has entered a stage of rapid development.However,due to the short development time of domestic companies,there is a large gap compared with foreign companies.At present,the domestic market is dominated by foreign companies.Based on the non-price competition strategy,the paper explores how to improve the competitiveness of in vitro diagnostic reagent companies in China,mainly analyzes the market structure and technological innovation of the in vitro diagnostic reagent industry,and emphasizes the importance of promoting the development of industrial concentration and the extension of large enterprises to the upstream of the value chain.

关 键 词：非价格竞争策略 产业集中化 价值链 技术创新 体外诊断试剂 

分 类 号：F279.23[经济管理—企业管理]